Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CHEMICAL PEELS (EFFECTIVE 09/01/2026) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IMMUNE CELL FUNCTION ASSAY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAOPERATIVE FLUORESCENCE IMAGING SYSTEMS (SPY IMAGING) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | POSITRON EMISSION TOMOGRAPHY (PET) FOR ONCOLOGIC CONDITIONS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTERSPINOUS / INTERLAMINAR STABILIZATION / DISTRACTION DEVICES (SPACERS) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SKIN AND TISSUE SUBSTITUTES (11/01/2025) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NERVE GRAFT WITH RADICAL PROSTATECTOMY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | EVALUATION OF BIOMARKERS FOR ALZHEIMER’S DISEASE - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | URINARY BIOMARKERS FOR BLADDER CANCER - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR MYOTONIC DYSTROPHY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PROACT ADJUSTABLE CONTINENCE THERAPY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LOW-DOSE RADIOFREQUENCY FOR NASAL VALVE REMODELING | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRANSPLANT-LUNG/DOUBLE LUNG AND LIVER (COMBINED) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CALCITONIN GENE RELATED PEPTIDE (CGRP) ANTAGONISTS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR PTEN HAMARTOMA TUMOR SYNDROME | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NAB-PACLITAXEL; PACLITAXEL PROTEIN-BOUND PARTICLES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SYNAGIS ( PALIVIZUMAB) - RETIRED - 2/12/2026 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SURGERY FOR GROIN PAIN IN ATHLETES - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAOPERATIVE FLUORESCENCE IMAGING SYSTEMS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AUTOMATED POINT-OF-CARE NERVE CONDUCTION TESTS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAVENOUS BISPHOSPHONATES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SUPRACHOROIDAL DELIVERY OF PHARMACOLOGIC AGENTS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR DUCHENNE AND BECKER MUSCULAR DYSTROPHY | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR RETT SYNDROME - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRANSMYOCARDIAL (PERVENTRICULAR) CLOSURE OF VENTRICULAR SEPTAL DEFECTS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENDOVASCULAR THERAPIES FOR EXTRACRANIAL VERTEBRAL ARTERY DISEASE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR RETINAL DYSTROPHIES - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MICROCURRENT ELECTRICAL NEUROSTIMULATION (MENS) - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RESPONSIVE NEUROSTIMULATION FOR THE TREATMENT OF REFRACTORY FOCAL EPILEPSY | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MAGNETOENCEPHALOGRAPHY/MAGNETIC SOURCE IMAGING - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MYELOPEROXIDASE (MPO) IMMUNOASSAY FOR CARDIAC DISEASE RISK | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CT (COMPUTED TOMOGRAPHY) PERFUSION IMAGING OF THE BRAIN | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NONCONTACT ULTRASOUND TREATMENT FOR WOUNDS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - FUSILEV - | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | FOCAL TREATMENTS FOR PROSTATE CANCER - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PHARMACOGENOMIC AND METABOLITE MARKERS FOR PATIENTS TREATED WITH THIOPURINES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INVASIVE PRENATAL (FETAL) DIAGNOSTIC TESTING DS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RETINAL POLARIZATION SCAN (RETINAL BIREFRINGENCE SCANNING) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | FECAL INCONTINENCE - INVESTIGATIONAL TREATMENTS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - CARRIER SCREENING FOR GENETIC DISEASES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LASER INTERSTITIAL THERMAL THERAPY FOR NEUROLOGICAL CONDITIONS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AQUEOUS SHUNTS AND STENTS FOR GLAUCOMA - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRANSTYMPANIC MICROPRESSURE APPLICATIONS AS A TREATMENT OF MENIERE'S DISEASE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ISLET CELL AUTOANTIBODY TESTING - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BCN ONLY: PHYSICAL AND OCCUPATIONAL THERAPY (OUTPATIENT) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | STEROID-ELUTING SINUS IMPLANTS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MICROPROCESSOR-CONTROLLED PROSTHESES AND ORTHOSES FOR THE LOWER LIMB | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TREATMENT OF HYPERHIDROSIS, EXCLUDING BOTULINUM - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PHESGO (PERTUZUMAB, TRASTUZUMAB AND HYALURONIDASE-ZZXF) J3590 | New policy |